Why Novel Cancer Vaccine Tested at UCSF Marks New Treatment Era
UCSF researchers helped test the first personalized mRNA cancer vaccine shown to prevent melanoma from returning or spreading, marking a breakthrough in cancer treatment.
Meta Settlement Puts Spotlight on Social Media Addiction in Kids
Jason Nagata, MD, MSc, discusses the health dangers of excessive social media use on the health of children, in response to an August 2026 announcement of a $17.1 billion settlement regarding children and teen addiction to their platform.
UCSF-Led Group Awarded $9 Million for Heart Inflammation Research
An international research network led in North America by UC San Francisco (UCSF) has received a $9 million award from the Leducq Foundation, a cardiovascular research funding organization, to uncover how the immune system attacks the heart and develop more precise treatments for myocarditis and other inflammatory heart muscle diseases.
UCSF QBI Is Awarded $46 Million to Advance Autism Research
The UCSF Quantitative Biosciences Institute (QBI) has received a significant grant to fund autism-related research.
Autism Decoded: New Science Is Opening Paths to Better Treatments
A study by Nevan Krogan and Matt State reveals protein interactions in the brain that are relevant to autism and epilepsy.
How Forever Chemicals May Raise Risks for Pregnant Women, Fetuses
Forever chemicals are in our water and our blood. Now, UCSF researchers are understanding what happens when they reach our placentas and what that means for pregnancies, mothers and their babies.
How to Teach T Cells to Track Cancer Like a Hound Dog
Scientists made universal stem-cell-derived dendritic "immune teacher" cells that can be coated with a patient’s tumor proteins, creating a cancer vaccine that activated tumor-killing T cells in laboratory studies, patient samples, and mouse models.